Pfizer Teams Up with Popit to Improve Medication Adherence

Pharmaceutical giant Pfizer has partnered up with health tech startup Popit.

Image: Popit

Pharmaceutical giant Pfizer has partnered up with health tech startup Popit to help people take their rheumatoid arthritis medication on time. Finland-based Popit is a former finalist of the Innovation World Cup®.

According to World Health Organization (WHO) estimate, around 50% of patients with long-term illnesses adhere to their medication.

Related Pilloxa Collaborates with Sandoz Nordics to Improve Medication Adherence

Pfizer will offer its patients Popit’s adherence solution, which monitors pill-taking with a smart device and alerts users via an app if they forget to take their medication, reports MobiHealth News.

Initially, 1,000 people living in Finland, Sweden and Norway will benefit from the new scheme. The company said it’s currently discussing about eventually expanding the system to other countries in central Europe.

Selected patients will be able to pick up the Popit device for free from either their pharmacy or health clinic.

Popit makes pills connected. This smart pill reminder reduces missed pills by over 80%.

Here’s How it Works

  • The small device called Popit Sense can be easily attached onto the pill sheet.
  • Small metal spikes pierce the pill sheet and offer excellent grip.
  • Three sensors work in a sequence to detect pill extraction automatically.
  • Popit Sense is also augmented with a manual logging button.

The tiny device weighs only 12 grams. Battery lasts for up to 12 months. Bluetooth range is up to 30m/100ft. The system provides seamless tracking and reminds you only if you have missed your pill.

Image: Wikimedia Commons

Why Rheumatoid Arthritis Patients?

Pfizer conducted a ‘deep dive’ into the treatment journey of rheumatoid arthritis patients. The company discovered that the patients weren’t receiving enough support in dealing with their condition.

Related cue-Rx Medication Adherence System to Deliver Prescription in their Original Containers

Pfizer’s partnership with Popit aims to support the proper implementation of these patients’ drug treatment.

“We want to increase the patient’s commitment to their treatment and also improve adherence so that treatment outcomes are better,” explains Popit cofounder, Timo Heikkilä.

“What is really game-changing with Popit’s solution is that it can be easily deployed for masses. There are no special requirements to the packaging and the device and app are very user friendly,” he adds.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Sam Draper
July 1, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

TWS Hearables Held The Biggest Share of Wearables Market in 2020: Counterpoint Research

In 2020, True Wireless Stereo (TWS) hearables were able to hold the most amount of stakes in the...

The Future of Wearable Computing May Be Augmented Reality – Newest Developments in AR Glasses

Augmented reality (AR) technology has seen unparalleled growth in 2020.Tech giants like Microsoft...

Coolpad Partners With M2MD To Develop Innovative Social Distancing and Contact Tracing Solutions For Workplace

Global consumer electronics company Coolpad announced that it has partnered with M2MD Tech...

French Gait Rehabilitation Provider FeetMe Raises €9.4M in Series A funding

FeetMe, a medical device company based in Paris, France has raised € 9.4 million in...
Discover more